Inappropriately overriding EHR alerts leads to a 6-fold increase in adverse drug events

Inappropriately overriding clinical decision support (CDS) in electronic health records (EHRs) was linked to a six-time increase in adverse drug events (ADEs), according to a study published Feb. 9 in BMJ Quality and Safety.

 

CDS in EHRs is meant to reduce medication errors and ADEs, but these alerts are often overridden in an inappropriate manner and could cause harm to patients. In this study, researchers from Brigham and Women’s Hospital evaluated the potential harm linked to CDS overrides in patients in the ICU.

Adults admitted to any of six ICUs from July 2016 to April 2017 at Brigham were analyzed for the study. Patients with provider-overridden CDS for dose, drug allergy, drug–drug interaction, geriatric and renal alerts were included.

Overall, a total of 2,448 override alerts were collected from 712 patient encounters. Results showed an 81.6 percent appropriateness rate for overrides. More ADEs followed inappropriate overrides compared to those that were appropriate. Inappropriate overrides were found to be linked to a six time increase in potential and definite ADEs when compared to appropriate overrides.

“Approximately four of five identified CDS overrides were appropriately overridden, though the rate varied substantially by alert type,” concluded first author Adrian Wong and colleagues. “Inappropriate overrides were six times as likely to be associated with an ADE (potential and definite) compared with appropriate overrides, confirming that decision support can identify clinically important situations. Further efforts should be targeted at improving the positive predictive value of CDS in a number of ways, including by following human factor principles in alert presentation, by suppressing alerts that are appropriately overridden, by using clinical information about individual patients to improve the likelihood that the alerts will be appropriate and by using techniques such as artificial intelligence to help determine which alerts to present.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”